Log in to search using one of your social media accounts:

 

More Hardcore Smokers Trying to Kick the Habit
Title: More Hardcore Smokers Trying to Kick the HabitCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - October 12, 2017 Category: Respiratory Medicine Source Type: news

SGS and Bavarian Nordic developing challenge strain to combat respiratory virus ​
ZURICH (Reuters) - SGS and Bavarian Nordic are teaming up to develop a virus challenge strain to combat a common respiratory illness. (Source: Reuters: Health)
Source: Reuters: Health - October 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical License Questions Sway Doctors ’ Mental Health Help
Asking only about current mental health may encourage help - seeking behavior (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 12, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Fall in nurse numbers could threaten patient safety
NHS even less equipped to cope with demands of a winter already set to stretch it to the limit Related items fromOnMedica Number of EU nurses registering drops by 96% Number of UK nurses and midwives falling Action plan to revive general practice nursing Poor admin support hampering respiratory nurses ’ time with patients Unrelenting NHS pressure affecting cancer care, say GPs and nurses (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 12, 2017 Category: UK Health Source Type: news

Death Toll from California Wildfires Expected to Rise
(MedPage Today) -- Hundreds treated in area hospitals for burns, respiratory issues (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - October 11, 2017 Category: Primary Care Source Type: news

Interference of griseofulvin with the segregation of chromosomes at mitosis in diploid Aspergillus nidulans
Low concentrations of the antibioticgriseofulvin were found to cause increased frequencies of somatic segregation due to chromosome nondisjunction in a diploid strain ofAspergillus nidulans. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Antifungal activity of statins against Aspergillus species
The cholesterol-lowering agents known as statins have in vitro activities against human pathogenic fungi, such as Candida species, Cryptococcus neoformans, and Zygomycetes. Synergy between statins and azoles against these fungi has also been reported. We evaluated the in vitro activities of two statins, lovastatin andsimvastatin, alone and in combination with azoles and amphotericin B, against clinical isolates ofAspergillus spp. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Growth inhibition of Candida species and Aspergillus fumigatus by statins.
Statins are a class of drugs widely used for lowering high cholesterol levels through their action on 3-hydroxy-3-methylglutaryl-CoA reductase, a key enzyme in the synthesis of cholesterol. We studied the effects of two major statins,simvastatin and atorvastatin, on five Candida species andAspergillus fumigatus. The statins strongly inhibited the growth of all species, except Candida krusei. Supplementation of Candida albicans and A. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review
The efficacy and safety of amorolfine 5% nail lacquer in combination with systemic antifungal agents in the treatment of the onychomycosis were evaluated. According to our meta-analysis, combination treatment of amorolfine 5% nail lacquer and systemic antifungals can result in higher percentage of complete clearance of onychomycosis. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis
The objective of this study was to investigate patient-reported outcomes (treatment utilisation, adherence and satisfaction) in onychomycosis treated with once-weeklyamorolfine 5% nail lacquer versus once-daily ciclopirox 8% nail lacquer (Study A) or once-daily urea 40% ointment/bifonazole 1% cream combination regimen (Study B). Study A: Subjects receivedamorolfine and ciclopirox on opposite feet for 12  weeks. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin H
Ilicicolin H is a polyketide-nonribosomal peptide synthase (NRPS)-natural product isolated from Gliocadium roseum, which exhibits potent and broad spectrum antifungal activity, with sub- μg/mL MICs against Candida spp., Aspergillus fumigatus, and Cryptococcus spp. It showed a novel mode of action, potent inhibition (IC50 = 2-3 ng/mL) of the mitochondrial cytochrome bc1 reductase, and over 1000-fold selectivity relative to rat liver cytochrome bc1 reductase. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis
Ambruticins are a family of polyketides. The antifungal activity of an ambruticin,KOSN-2079, was tested in the mouse model of invasive aspergillosis.KOSN-2079 significantly reduced pulmonary fungal burdens and improved survival over that with the vehicle control. These results support the continued development of ambruticins as antifungal agents. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice
The activities ofR-135853, a novel sordarin derivative that possesses a 1,4-oxazepane ring moiety, were evaluated in vitro and in vivo.R-135853 exhibited potent in vitro activities against Candida albicans (fluconazole-susceptible strains), Candida glabrata, Candida tropicalis, and Cryptococcus neoformans, with MICs at which 90% of isolates were inhibited of 0.03, 1, 0.5, and 0.5 microg/ml, respectively. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
Candida is the most common fungal pathogen of humans worldwide and has become a major clinical problem because of the growing number of immunocompromised patients, who are susceptible to infection. Moreover, the number of available antifungals is limited, and antifungal-resistantCandida strains are emerging. New and effective antifungals are therefore urgently needed. Here, we discovered a small molecule with activity againstCandida spp. bothin vitro andin vivo. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
Recent estimates suggest that>300 million people are afflicted by serious fungal infections worldwide. Currentantifungal drugs are static and toxic and/or have a narrow spectrum of activity. Thus, there is an urgent need for the development of newantifungal drugs. The fungal sphingolipid glucosylceramide (GlcCer) is critical in promoting virulence of a variety of human-pathogenic fungi. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 11, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Is Pleurisy Contagious?
Title: Is Pleurisy Contagious?Category: Diseases and ConditionsCreated: 3/15/2016 12:00:00 AMLast Editorial Review: 10/11/2017 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - October 11, 2017 Category: Respiratory Medicine Source Type: news

Disaster Cleanup and Recovery PPE (Personal Protective Equipment) Matrix
Occupational Safety and Health Administration [U.S. Department of Labor]. 10/2016 This two-page document and matrix will assist employers in determining the personal protective equipment (PPE) needed for the hazards that workers engaged in disaster cleanup and recovery activities may be exposed to. It also discusses respiratory protection, and sanitation and hygiene. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 11, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Rapid Risk Assessment: Public Health Risks Related to Communicable Diseases During the Hajj 2017, Saudi Arabia, 30 August-4 September 2017
European Union, European Centre for Disease Prevention and Control. 08/10/2017 This 13-page report assesses the potential health risks for communicable diseases and other health threats for European citizens during their stay in Saudi Arabia for the Hajj pilgrimage on August 30-September 4, 2017. The risk of communicable disease outbreaks is highest for food- and waterborne diseases and respiratory illnesses due to crowding, but the risk is not considered higher than expected for international mass gatherings. MERS-CoV activity continues to be reported in the Arabian Peninsula, and imported cases may be detected in Europe ...
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - October 11, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news

Propeller Health releases asthma forecasting API for open use
Madison, Wisconsin-based Propeller Health is taking its asthma alert messaging to the masses, as the longtime digital respiratory health company announced today that it is releasing Air, a free and open API that provides information on local asthma conditions. (Source: mobihealthnews)
Source: mobihealthnews - October 10, 2017 Category: Information Technology Source Type: news

New Connected Devices Seek to Tackle Drug Noncompliance
Noncompliance with drug regimens continues to be a significant healthcare concern. “Today, 60% of patients fail to comply with their medication regimen,” Sai Shankar, director business development - connected devices for Aptar Pharma, tells MD+DI.   Aptar Pharma believes that turning metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs) into connected devices could have an impact. “This can improve patient engagement and significantly increase dose adherence and improve patient health outcomes, as patients manage their treatments more effectively,” says Shankar. “Connected ...
Source: MDDI - October 10, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Digital Health Source Type: news

Respicardia wins FDA nod for Remed ē central sleep apnea neurostim device
Respicardia said today that it won FDA approval for its Remedē transvenous implantable neurostimulation system designed to treat patients with central sleep apnea. Central sleep apnea occurs when the brain fails to control breathing during sleep, unlike the more common obstructive sleep apnea which consists of a partially collapsed airway which causes pauses in breathing, Respicardia said. The Remedē system consists of a surgically placed battery packa nd thin wires inserted into the blood vessels in the chest near the phrenic nerve, which it stimulates to engage the diaphragm to restore natural breating during sleep and...
Source: Mass Device - October 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Respiratory Respicardia Source Type: news

Medtronic breaks ground on western China Innovation Center
Medtronic (NYSE:MDT) said today it has begun work on an Innovation Center in Chengdu, China, slated to open in 2020. The new Chengdu Innovation Center is being built at the Singapore-Sichuan Hi-Tech Innovation Park in the Sichuan Province and aims to provide clinical training and research platforms for medical workers in the region and neighboring regions. “Medtronic understands the critical role that rural physicians play in driving the healthcare availability and transformation. As such, we hope to support the growth and development of medical workers in China’s vast central and western regions, help the...
Source: Mass Device - October 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Medtronic Source Type: news

Drugs in Clinical Development for Fungal Infections (includes MAT023, encochleated amphotericin B))
Despite increasing rates of invasive fungal infections being reported globally, only a single antifungal drug has been approved during the last decade. Resistance, toxicity, drug interactions and restricted routes of administration remain unresolved issues. This review focuses on new antifungal compounds which are currently in various clinical phases of development. We discuss two azoles with a tetrazole moiety that allows selective activity against the fungal CYP: VT-1161 for Candida infections and VT-1129 for cryptococcal meningoencephalitis. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase
AR-12/OSU-03012 is an antitumor celecoxib-derivative that has progressed to Phase I clinical trial as an anticancer agent and has activity against a number of infectious agents including fungi, bacteria and viruses. However, the mechanism of these activities has remained unclear. Based on a chemical-genetic profiling approach in yeast, we have found thatAR-12 is an ATP-competitive, time-dependent inhibitor of yeast acetyl coenzyme A synthetase. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis
Only one new class of antifungal drugs has been introduced into clinical practice in the last 30 years, and thus the identification of small molecules with novel mechanisms of action is an important goal of current anti-infective research. Here, we describe the characterization of the spectrum of in vitro activity and in vivo activity ofAR-12, a celecoxib derivative which has been tested in a phase I clinical trial as an anticancer agent. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition
The synthesis and antifungal activity ofASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition and significantly improved MIC against Candida parapsilosis and echinocandin resistant-Candida is described. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis
ASP9726 is an investigational echinocandin with in vitro activity against Aspergillus species. We evaluated the pharmacokinetics and efficacy of this agent in an established guinea pig model of invasive pulmonary aspergillosis.ASP9726 plasma concentrations were measured in guinea pigs administered either a single dose or multiple doses of this agent at 2.5, 5, and 10 mg/kg of body weight/day by subcutaneous injection. Immunosuppressed guinea pigs were inoculated with A. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Generation of Broad-Spectrum Antifungal Drug Candidates from the Natural Product Compound Aureobasidin A
This report describes novel chemistry for the modification of AbA. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity.
We report the molecular cloning and characterization of the Aspergillus nidulans aurA gene, which is homologous to AUR1. A single point mutation in the aurA gene of A. nidulans confers a high level of resistance toaureobasidin A. The A. nidulans aurA gene was used to identify its homologs in other Aspergillus species, including A. fumigatus, A. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Structure of aureobasidin A
Aureobasidin A, a new antifungal antibiotic, was isolated from the culture medium of Aureobasidium pullulans R106.Aureobasidin A was a cyclic depsipeptide consisting of eight alpha-amino acid units and one hydroxy acid unit. The structures of the units were found by acid hydrolysis of the antibiotic to be 2(R)-hydroxy-3(R)-methylpentanoic acid, beta-hydroxy-N-methyl-L-valine, N-methyl-L-valine, L-proline, allo-L-isoleucine, N-methyl-L-phenylalanine, L-leucine, and L-phenyl-alanine. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Seeking Cochrane Systematic Reviewer - Cochrane Airways, London, UK
Salary:£32,548 to £38,883 plus London Allowance of £3,027Type: Fixed TermClosing Date: Monday 23 October 2017Interview Date: Wednesday 01 November 2017We are looking for a full-time systematic reviewer to join Cochrane Airways for three years to undertake a set of reviews about respiratory conditions. The reviews will use diverse methods and will be conducted in conjunction with the editorial team, international authors, the NIHR Complex Review Support Unit and NICE.The successful candidate will be a graduate with experience in and enthusiasm for systematic review. The post-holder will be familiar with re...
Source: Cochrane News and Events - October 10, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news

FR290581, a novel sordarin derivative: synthesis and antifungal activity
Sordarin is a unique natural product antifungal agent that is an inhibitor of elongation factor 2. To improve biological activity, we synthesized various compounds by novel modification of the aglycone, sordaricin. As a result, we have discovered the novel sordarin derivativeFR290581. This compound exhibited superior activity and a good pharmacokinetic profile, and also displayed good in vivo activity against Candida albicans. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Correlation between In Vitro and In Vivo Activities of GM 237354, a New Sordarin Derivative, against Candida albicans in an In Vitro Pharmacokinetic-Pharmacodynamic Model and Influence of Protein Binding
The antifungal effect ofGM 237354, a sordarin derivative, was studied in an in vitro pharmacokinetic (PK)-pharmacodynamic dynamic system (bioreactor) which reproduces PK profiles observed in a previously described model of drug efficacy against murine systemic candidiasis. Immunocompetent mice infected intravenously with 10(5) CFU of Candida albicans were treated withGM 237354 at 2.5, 10, and 40 mg/kg of body weight every 8 h subcutaneously for 7 days. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 10, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news

Lung deaths and smoking diseases spike among impoverished populations
(Natural News) The number of Americans dying due to a chronic respiratory disease has increased by 30 percent in 34 years mainly among the poverty-stricken populations, according to a report by The Daily Mail. The researchers behind the University of Washington study analyzed the death records for chronic respiratory diseases from 1980 to 2014 from the... (Source: NaturalNews.com)
Source: NaturalNews.com - October 10, 2017 Category: Consumer Health News Source Type: news

Adding Albumin to Risk Score Improves Mortality Prediction
In patients undergoing transcatheter aortic valve replacement, low albumin tied to higher mortality (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 10, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Internal Medicine, Critical Care, Nursing, Pathology, Pulmonology, Surgery, Journal, Source Type: news

2016 Physician Quality Reporting System Reports Available
Physicians should review reports to know whether they are subject to 2018 PQRS payment adjustment (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 10, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news

Injured Patients Want More Info on Safety Improvement Efforts
Eighteen of 30 patients and family members reported the CRP experience to be positive overall (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 10, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Fewer Newborns Get Whooping Cough When Moms Get Vaccinated Fewer Newborns Get Whooping Cough When Moms Get Vaccinated
Vaccinating mothers against whooping cough during pregnancy may prevent 9 out of 10 severe cases of this potentially fatal respiratory infection in their babies, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 9, 2017 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Children Who Survive Heart Disease Face Challenges
Many of these children can also suffer from illnesses such as autism and respiratory conditions, study says (Source: WebMD Health)
Source: WebMD Health - October 9, 2017 Category: Consumer Health News Source Type: news

Surviving Congenital Heart Disease as Child Not a Ticket to Good Health
Many of these children can also suffer from illnesses such as autism and respiratory conditions, study says Source: HealthDay Related MedlinePlus Pages: Congenital Heart Defects (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 9, 2017 Category: Consumer Health News Source Type: news

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia
Between 31 August and 26 September 2017, the national IHR focal point of Saudi Arabia reported nine additional cases of Middle East Respiratory Syndrome (MERS), including four deaths. In addition, four deaths from previously reported cases were reported. (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - October 9, 2017 Category: Infectious Diseases Tags: news Source Type: news

Respiratory Health Status in HIV-Positive Adults Respiratory Health Status in HIV-Positive Adults
HIV-positive individuals on effective ART had worse respiratory health status compared with HIV-negative people.HIV Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2017 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news

Asthma attacks cut in half by vitamin D supplements, study finds
(Natural News) A study has found a better option for treating or lowering the risk of asthma, as reported by The Daily Mail. Aside from strengthening the bones and muscles, vitamin D supplements can also lessen the risk of respiratory problems, such as severe asthma by 50 percent, according to the new study. “Vitamin D... (Source: NaturalNews.com)
Source: NaturalNews.com - October 8, 2017 Category: Consumer Health News Source Type: news

Respiratory illnesses harsher on women
​Chronic lower respiratory illness (CLRI) ranks as the third-leading cause of death for women of all ages. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 8, 2017 Category: American Health Authors: Bill Chasten Source Type: news

Respiratory illnesses harsher on women
​Chronic lower respiratory illness (CLRI) ranks as the third-leading cause of death for women of all ages. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 8, 2017 Category: Biotechnology Authors: Bill Chasten Source Type: news

Medical News Today: Pneumoconiosis: Symptoms, risk factors, and management
Pneumoconiosis is a lung disease caused by dust particles. In this article, learn more about pneumoconiosis, its symptoms, risk factors, and management. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 8, 2017 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Fewer newborns get whooping cough when moms get vaccinated
(Reuters Health) - Vaccinating mothers against whooping cough during pregnancy may prevent 9 out of 10 severe cases of this potentially fatal respiratory infection in their babies, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 6, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Concerned about Overheating? Consider a New Heat Source
To reduce the risks of medical devices overheating in the field, Minco Products Inc. has just launched its SmartHeat SLT (Self-Limiting Technology) line of thin-film heaters suitable for a range of constant-temperature applications. Healthcare uses include IV fluid heating, diagnostic reagent heating, oxygen humidifiers for surgery, saline heaters for sleep apnea devices, and other home health devices. The thin film—measuring just 0.0013 in. thick—can be cut out, sized, and wrapped around items for lining tanks and tubes. It can even survive being cut, torn, or punctured in the field, with some exceptions....
Source: MDDI - October 6, 2017 Category: Medical Devices Authors: Daphne Allen Tags: MD & M West (Anaheim) Materials Source Type: news

Vical announces Phase 2 efficacy trial for antifungal VL-2397
Fri, 10/06/2017 - 16:50News blog (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 6, 2017 Category: Respiratory Medicine Authors: BethBradshaw Source Type: news